Trials / Conditions / Recurrent Astrocytoma, IDH-Mutant, Grade 4
Recurrent Astrocytoma, IDH-Mutant, Grade 4
4 registered clinical trials studyying Recurrent Astrocytoma, IDH-Mutant, Grade 4 — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | GI-102 Alone or With Pembrolizumab Before Surgery for Treatment of Recurrent or Progressive IDH Wildtype Gliob NCT07301268 | Mayo Clinic | Phase 2 |
| Suspended | Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblasto NCT06860594 | National Cancer Institute (NCI) | Phase 1 |
| Recruiting | Intracranial Genetically Modified Immune Cells (TGFβR2KO/IL13Rα2 CAR T-Cells) for the Treatment of Recurrent o NCT06815029 | City of Hope Medical Center | Phase 1 |
| Recruiting | Allogenic Adipose-Derived Mesenchymal Stem Cells for the Treatment of Recurrent Glioblastoma or Recurrent Astr NCT05789394 | Mayo Clinic | Phase 1 |